15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Amrize Ltd, 5 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $48.00 to $70.00, a moderate spread. The average target of $61.13 sits 21% above the current $50.37. The rating mix has stayed broadly stable, with Buy-side ratings easing from 8 to 5 over recent months. On the fundamentals, the Street sees revenue growth near 5% this year and 6% next, consensus EPS building from about $1.16 next quarter toward $3.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy556%
Hold444%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Amrize Ltd.
As of Jul, 5 of 9 firms rate AMRZ a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AMRZ EPS & revenue forecast
EPS · NEXT QUARTER
$1.16
Range $1.07 – $1.22 · 7 analysts · +19% YoY
Next period, 7 analysts expect Amrize Ltd to earn $1.16 a share (range $1.07 – $1.22), versus $0.98 a year earlier. Full-year consensus is $2.68, growing to $3.10 the year after.
REVENUE · NEXT QUARTER
$3.8B
Range $3.7B – $3.9B · 7 analysts · +4% YoY
Revenue is expected to reach $3.8B (range $3.7B – $3.9B), +4.0% year-over-year. Full-year consensus is $12.4B, rising to $13.1B next year.
Top analysts covering Amrize Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AMRZ.
#1
AP
Anthony Pettinari
Citigroup · Rank #84
Buy
$66.00+31.0% to target
Overall win rate
45%
+ Follow
#2
Timna Tanners
Wells Fargo
Buy
$58.00+15.1% to target
Coverage
—
+ Follow
#3
Bryan Blair
Oppenheimer
Buy
$65.00+29.0% to target
Coverage
—
+ Follow
#4
Keith Hughes
Truist Securities
Hold
$48.00-4.7% to target
Coverage
—
+ Follow
#5
AC
Anthony Codling
RBC Capital
Hold
$60.00+19.1% to target
Coverage
—
+ Follow
AMRZ stock forecast FAQ
What is AMRZ's average 12-month price target?+
The 8 analysts with a live target average $61.13 for Amrize Ltd over the next 12 months, ranging from a $70.00 high to a $48.00 low.
Is AMRZ stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 5 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AMRZ?+
The Street-high target is $70.00 (JP Morgan), and the Street-low is $48.00 (Truist Securities). The average of all 8 active targets is $61.13.
How many Wall Street analysts cover AMRZ?+
9 analysts have an active rating on Amrize Ltd, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering AMRZ?+
Among analysts who currently cover AMRZ, Anthony Pettinari of Citigroup has the strongest overall Quantellect track record (Rank #84). Their current call is Buy with a $66.00 target.
What is Amrize Ltd's projected EPS for next quarter?+
The consensus estimate is $1.16 per share (range $1.07 – $1.22) across 7 analysts. Full-year EPS is projected at $2.68, rising to $3.10 the following year.
How much revenue is Amrize Ltd expected to report next quarter?+
Consensus revenue is $3.8B (range $3.7B – $3.9B). Full-year revenue is projected at $12.4B, growing to $13.1B next year.
Have analysts been upgrading or downgrading AMRZ lately?+
As of Jul, 5 of 9 firms rate AMRZ a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AMRZ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
